Kaller; Matthew R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kaller; Matthew R..The latest application filed is for "compounds that inhibit mcl-1 protein".
Company Profile
5.29.29
- Kaller; Matthew R. - Thousand Oaks CA
- Kaller; Matthew R. - Ventura CA
Patent Activity
| Patent | Date |
|---|---|
| Compounds that inhibits MCL-1 protein Grant 11,224,601 - Harrington , et al. January 18, 2 | 2022-01-18 |
| Heteroaryl-substituted triazoles as APJ receptor agonists Grant 11,046,680 - Chen , et al. June 29, 2 | 2021-06-29 |
| Compounds that inhibit Mcl-1 protein Grant 10,821,115 - Harrington , et al. November 3, 2 | 2020-11-03 |
| Compounds That Inhibit Mcl-1 Protein App 20200171043 - HARRINGTON; Paul E. ; et al. | 2020-06-04 |
| Compounds that inhibit Mcl-1 protein Grant 10,632,128 - Harrington , et al. | 2020-04-28 |
| Compounds That Inhibit Mcl-1 Protein App 20190381064 - HARRINGTON; Paul E. ; et al. | 2019-12-19 |
| Triazole agonists of the APJ receptor Grant 10,221,162 - Chen , et al. | 2019-03-05 |
| Triazole Agonists Of The Apj Receptor App 20180319773 - CHEN; Ning ; et al. | 2018-11-08 |
| Compounds That Inhibit Mcl-1 Protein App 20180289720 - Harrington; Paul E. ; et al. | 2018-10-11 |
| Methods of treating heart failure Grant 10,058,550 - Chen , et al. August 28, 2 | 2018-08-28 |
| Triazole agonists of the APJ receptor Grant 9,868,721 - Chen , et al. January 16, 2 | 2018-01-16 |
| Intermediates for preparing triazole agonists of the APJ receptor Grant 9,845,310 - Chen , et al. December 19, 2 | 2017-12-19 |
| Methods Of Treating Heart Failure App 20170281625 - Chen; Ning ; et al. | 2017-10-05 |
| Methods for preparing triazole agonists of the APJ receptor Grant 9,751,864 - Chen , et al. September 5, 2 | 2017-09-05 |
| Triazole agonists of the APJ receptor Grant 9,745,286 - Chen , et al. August 29, 2 | 2017-08-29 |
| Triazole agonists of the APJ receptor Grant 9,656,997 - Chen , et al. May 23, 2 | 2017-05-23 |
| Intermediates for preparing triazole agonists of the APJ receptor Grant 9,656,998 - Chen , et al. May 23, 2 | 2017-05-23 |
| Triazole agonists of the APJ receptor Grant 9,573,936 - Chen , et al. February 21, 2 | 2017-02-21 |
| Triazole Agonists Of The Apj Receptor App 20170044131 - CHEN; Ning ; et al. | 2017-02-16 |
| Triazole Agonists Of The Apj Receptor App 20170042872 - CHEN; Ning ; et al. | 2017-02-16 |
| Triazole Agonists Of The Apj Receptor App 20170042871 - Chen; Ning ; et al. | 2017-02-16 |
| Triazole Agonists Of The Apj Receptor App 20170042897 - Chen; Ning ; et al. | 2017-02-16 |
| Triazole Agonists Of The Apj Receptor App 20170037026 - CHEN; Ning ; et al. | 2017-02-09 |
| Triazole Agonists Of The Apj Receptor App 20170035744 - CHEN; Ning ; et al. | 2017-02-09 |
| Triazole Agonists Of The Apj Receptor App 20160340336 - Chen; Ning ; et al. | 2016-11-24 |
| Azetidine and piperidine compounds useful as PDE10 inhibitors Grant 9,493,459 - Allen , et al. November 15, 2 | 2016-11-15 |
| Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors Grant 9,376,450 - Allen , et al. June 28, 2 | 2016-06-28 |
| Azetidine And Piperidine Compounds Useful As Pde10 Inhibitors App 20160176874 - ALLEN; Jennifer R. ; et al. | 2016-06-23 |
| Azetidine and piperidine compounds useful as PDE10 inhibitors Grant 9,303,028 - Allen , et al. April 5, 2 | 2016-04-05 |
| TRPM8 antagonists and their use in treatments Grant 9,096,527 - Biswas , et al. August 4, 2 | 2015-08-04 |
| Chroman derivatives as TRPM8 inhibitors Grant 8,952,009 - Biswas , et al. February 10, 2 | 2015-02-10 |
| Chroman Derivatives As Trpm8 Inhibitors App 20150031668 - Biswas; Kaustav ; et al. | 2015-01-29 |
| TRPM8 antagonists and their use in treatments Grant 8,778,941 - Brown , et al. July 15, 2 | 2014-07-15 |
| Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors Grant 8,759,532 - Allen , et al. June 24, 2 | 2014-06-24 |
| Trpm8 Antagonists And Their Use In Treatments App 20140171639 - Biswas; Kaustav ; et al. | 2014-06-19 |
| Trpm8 Antagonists And Their Use In Treatments App 20140171406 - Biswas; Kaustav ; et al. | 2014-06-19 |
| Azetidine And Piperidine Compounds Useful As Pde10 Inhibitors App 20140148435 - Allen; Jennifer R. ; et al. | 2014-05-29 |
| TRPM8 antagonists and their use in treatments Grant 8,710,043 - Chen , et al. April 29, 2 | 2014-04-29 |
| Azetidine and piperidine compounds useful as PDE10 inhibitors Grant 8,691,986 - Allen , et al. April 8, 2 | 2014-04-08 |
| Chroman Derivatives As Trpm8 Inhibitors App 20140045855 - BISWAS; Kaustav ; et al. | 2014-02-13 |
| Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors Grant 8,637,500 - Allen , et al. January 28, 2 | 2014-01-28 |
| Azetidine And Piperidine Compounds Useful As Pde10 Inhibitors App 20130338138 - Allen; Jennifer R. ; et al. | 2013-12-19 |
| Heteroaryloxyheterocyclyl Compounds As Pde10 Inhibitors App 20130253186 - Allen; Jennifer R. ; et al. | 2013-09-26 |
| Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors Grant 8,497,265 - Allen , et al. July 30, 2 | 2013-07-30 |
| Trpm8 Antagonists And Their Use In Treatments App 20130158034 - BROWN; James ; et al. | 2013-06-20 |
| Trpm8 Antagonists And Their Use In Treatments App 20130157996 - Biswas; Kaustav ; et al. | 2013-06-20 |
| Pyridine And Pyrimidine Derivatives As Phosphodiesterase 10 Inhibitors App 20130079325 - Allen; Jennifer R. ; et al. | 2013-03-28 |
| Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors Grant 8,318,718 - Allen , et al. November 27, 2 | 2012-11-27 |
| Heteroaryloxyheterocyclyl Compounds As Pde10 Inhibitors App 20110306588 - Allen; Jennifer R. ; et al. | 2011-12-15 |
| Aminopyridine And Carboxypyridine Compounds As Phosphodiesterase 10 Inhibitors App 20100160280 - Allen; Jennifer R. ; et al. | 2010-06-24 |
| Pyridine And Pyrimidine Derivatives As Phosphodiesterase 10 Inhibitors App 20100125062 - Allen; Jennifer R. ; et al. | 2010-05-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 